"From the hospital bedside to the offices of global governments, my primary focus has always been improving and protecting the health and well-being of patients."
Trained as an oncology clinical nurse specialist, Marguerite joined the National Institutes of Health’s (NIH) National Cancer Institute (NCI) to guide the clinical nursing care for patients participating in clinical trials. Having worked in political campaigns, Marguerite transitioned into an NIH AIDS policy coordination role which eventually led to a 22 year career in government affairs and public policy in the private sector. Marguerite has represented numerous biopharmaceutical companies, nonprofit patient organizations, foundations and academic medical research institutions, such as the Johns Hopkins University, Fred Hutchinson Cancer Research Center and Columbia University. For the past 11 years Marguerite has worked on global public policy and government affairs issues in the C-Suite of two Fortune 100 companies and a global biotech company. Marguerite’s leadership experience in Novartis Vaccines and Diagnostics, Inc., Chiron Corporation and Pharmacia Corporation (Pfizer) has enabled her to be at the forefront of policy opportunities in biopharmaceutical innovation in the evolving global health care systems.
➢ HHS Secretary Award for Outstanding Accomplishment for efforts in newly created role coordinating AIDS research policy
➢ Currently serves on the board of directors of C-Change, a National Dialogue on Cancer, Friends of Cancer Research and the National Coalition for Cancer Research